Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type  | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Wyeth Pharmaceuticals Company, Inc. | Pfizer | pharmaceuticals | water pollution violation | 2010 | EPA | $77,000 |
| Merck and Company | Merck | pharmaceuticals | water pollution violation | 2008 | EPA | $6,075,000 |
| Pernix Therapeutics, LLC | Currax Pharmaceuticals | pharmaceuticals | WARN Act violation | 2019 | private lawsuit-federal | $300,000 |
| Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
| General Nutrition Corporation | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2017 | MA-AG | $72,304 |
| Synthes USA | Johnson & Johnson | pharmaceuticals | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2015 | private lawsuit-federal | $350,014 |
| Mylan | Viatris | pharmaceuticals | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
| Novartis | Novartis | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
| Genentech | Roche | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
| Genentech | Roche | pharmaceuticals | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2005 | private lawsuit-federal | $60,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
| Pharmavite LLC | Otsuka Pharmaceutical | pharmaceuticals | wage and hour violation | 2017 | private lawsuit-state | $1,925,000 |
| Baxalta US Inc. | Takeda Pharmaceutical | pharmaceuticals | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
| Depuy Synthes Sales, Inc. | Johnson & Johnson | pharmaceuticals | wage and hour violation | 2020 | CA-LCO | $57,488 |
| Allergan Inc | AbbVie | pharmaceuticals | wage and hour violation | 2019 | MI-LEO | $7,656 |
| Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | pharmaceuticals | wage and hour violation | 2018 | MI-LEO | $12,500 |
| Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | pharmaceuticals | wage and hour violation | 2018 | MI-LEO | $5,070 |
| Allergan Usa Inc | AbbVie | pharmaceuticals | wage and hour violation | 2017 | MI-LEO | $64,828 |
| Allergan Plc | AbbVie | pharmaceuticals | wage and hour violation | 2016 | MI-LEO | $73,999 |
| Allergan Usa Inc | AbbVie | pharmaceuticals | wage and hour violation | 2016 | MI-LEO | $73,999 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | wage and hour violation | 2014 | MI-LEO | $13,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | wage and hour violation | 2014 | MI-LEO | $5,885 |
| AKORN OPERATING COMPANY LLC | Akorn Inc. | pharmaceuticals | wage and hour violation | 2023 | IL-DOL | $13,000 |
| AKORN OPERATING COMPANY LLC | Akorn Inc. | pharmaceuticals | wage and hour violation | 2023 | IL-DOL | $10,600 |
| Akorn Inc | Akorn Inc. | pharmaceuticals | wage and hour violation | 2023 | IL-DOL | $15,000 |
| ABBVIE INC | AbbVie | pharmaceuticals | wage and hour violation | 2022 | IL-DOL | $27,330 |
| Akorn Inc | Akorn Inc. | pharmaceuticals | wage and hour violation | 2022 | IL-DOL | $7,000 |
| ABBVIE US LLC | AbbVie | pharmaceuticals | wage and hour violation | 2021 | IL-DOL | $25,973 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | tax violations | 2007 | IRS | $2,300,000,000 |
| PHIBRO-TECH, INC. | Phibro Animal Health | pharmaceuticals | railroad safety violation | 2008 | FRA | $5,650 |
| Mallinckrodt | Mallinckrodt | pharmaceuticals | railroad safety violation | 2007 | FRA | $10,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | railroad safety violation | 2002 | FRA | $11,250 |
| Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | railroad safety violation | 2006 | FRA | $6,800 |
| Cherokee Pharmaceuticals | Merck | pharmaceuticals | railroad safety violation | 2021 | FRA | $5,000 |
| Malincrodt Chemical Company | Mallinckrodt | pharmaceuticals | railroad safety violation | 2022 | FRA | $7,500 |
| Mallinckrodt, Inc. | Mallinckrodt | pharmaceuticals | radioactive waste violation | 2008 | GA-ENV | $5,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
| Eli Lilly & Co. | Eli Lilly | pharmaceuticals | privacy violation | 2002 | MULTI-AG | $160,000 |
| CSL Plasma Inc. | CSL Limited | pharmaceuticals | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| Merck KgaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
| Alpharma, Inc. | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
| Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
| Barr Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
| Bausch & Lomb | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
| CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
| Geneva Pharmaceuticals | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
| Merck KGaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
| Perrigo Company | Perrigo | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Ranbaxy Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
| Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
| UCB Pharma, Inc. | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Warner Chilcott Holdings | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
| Apotex Corp. | Apotex Corp. | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $10,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
| Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
| Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $934,903 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $1,003,634 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $806,991 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $15,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $3,000,000 |
| Allergan, Inc. | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $13,450,000 |
| American BioScience Inc. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
| Amgen Inc. | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
| Astellas Pharma US, Inc. | Astellas Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
